{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T23:36:18Z","timestamp":1790638578687,"version":"4.1.0"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T00:00:00Z","timestamp":1772409600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Given the limitations of current treatments for Alzheimer\u2019s disease (AD), this study aims to comprehensively evaluate the therapeutic efficacy of human umbilical cord mesenchymal stem cells (hUCMSCs) in AD mouse models through a systematic review and meta-analysis. Additionally, we explore the impact of transplantation dose and route on treatment outcomes to identify the optimal window for clinical application.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In accordance with the PRISMA guidelines, we systematically searched four major databases to identify randomized controlled trials involving hUCMSCs in AD mouse models. We used the standardized mean difference (SMD) to synthesize effect sizes and performed subgroup analyses based on pre-defined transplantation routes and doses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 13 studies were included in the analysis. The meta-analysis revealed that hUCMSCs transplantation significantly improved spatial learning and memory in AD model mice, with a marked reduction in escape latency (SMD\u202f=\u202f\u22122.55; 95% CI: \u22123.34 to \u22121.75;\n                      <jats:italic>I<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      \u202f=\u202f77.9%, random-effects model). Additionally, it significantly lowered brain \u03b2-amyloid levels (SMD\u202f=\u202f\u22125.34; 95% CI: \u22127.21 to \u22123.47;\n                      <jats:italic>I<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      \u202f=\u202f80.3%), increased brain-derived neurotrophic factor (SMD\u202f=\u202f4.25; 95% CI: 3.18 to 5.31), and reduced neuronal apoptosis (SMD\u202f=\u202f\u22124.96; 95% CI: \u22126.52 to \u22123.41). Subgroup analyses further revealed that efficacy was significantly dose- and route-dependent. For cognitive improvement, intravenous injection of medium to high doses (\u22651\u202f\u00d7\u202f10\n                      <jats:sup>6<\/jats:sup>\n                      cells) was most effective and robust. For amyloid-\u03b2 clearance, low-dose administration via intravenous, lateral ventricle, and cortical routes showed significant efficacy, whereas bilateral hippocampal injection did not yield significant benefits.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Human umbilical cord mesenchymal stem cells can improve behavioral and pathological outcomes in AD mouse models via multiple mechanisms of action. The intravenous route using medium to high doses emerges as a critical factor for achieving optimal effects, providing important evidence and informing future experimental design and clinical translational research.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fneur.2026.1783757","type":"journal-article","created":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T05:21:08Z","timestamp":1772428868000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Human umbilical cord mesenchymal stem cells therapy for Alzheimer\u2019s disease: a systematic review and meta-analysis of mouse models"],"prefix":"10.3389","volume":"17","author":[{"given":"Chunyan","family":"Si","sequence":"first","affiliation":[{"name":"Gansu Provincial Hospital of Traditional Chinese Medicine","place":["Lanzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Ma","sequence":"additional","affiliation":[{"name":"Gansu Provincial Hospital of Traditional Chinese Medicine","place":["Lanzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Ding","sequence":"additional","affiliation":[{"name":"Gansu Provincial Hospital of Traditional Chinese Medicine","place":["Lanzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunxia","family":"Tian","sequence":"additional","affiliation":[{"name":"Gansu Provincial Hospital of Traditional Chinese Medicine","place":["Lanzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Zhang","sequence":"additional","affiliation":[{"name":"Gansu Provincial Hospital of Traditional Chinese Medicine","place":["Lanzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Cao","sequence":"additional","affiliation":[{"name":"Gansu Provincial Hospital of Traditional Chinese Medicine","place":["Lanzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya","family":"Shao","sequence":"additional","affiliation":[{"name":"Gansu Provincial Hospital of Traditional Chinese Medicine","place":["Lanzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqiang","family":"Fan","sequence":"additional","affiliation":[{"name":"Gansu Provincial Hospital of Traditional Chinese Medicine","place":["Lanzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,2]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1016\/S0140-6736(25)01294-2","article-title":"New landscape of the diagnosis of Alzheimer's disease","volume":"406","author":"Frisoni","year":"2025","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"2198","DOI":"10.1016\/S0140-6736(24)01883-X","article-title":"Passive anti-amyloid \u03b2 immunotherapy in Alzheimer's disease-opportunities and challenges","volume":"404","author":"Heneka","year":"2024","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/S1474-4422(24)00038-3","article-title":"Global, regional, and national burden of disorders affecting the nervous system, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021","volume":"23","year":"2024","journal-title":"Lancet Neurol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1001\/jama.2025.21738","article-title":"Valacyclovir Treatment of Early Symptomatic Alzheimer Disease: The VALAD Randomized Clinical Trial","volume":"335","author":"Devanand","year":"2026","journal-title":"JAMA"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1016\/s0140-6736(25)01389-3","article-title":"Alzheimer's disease outlook: controversies and future directions","volume":"406","author":"Frisoni","year":"2025","journal-title":"Lancet"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1056\/NEJMoa2308719","article-title":"Ultrasound Blood-Brain Barrier Opening and Aducanumab in Alzheimer\u2019s Disease","volume":"390","author":"Rezai","year":"2024","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"832199","DOI":"10.3389\/fneur.2022.832199","article-title":"Neuropsychiatric or behavioral and psychological symptoms of dementia (BPSD): focus on prevalence and natural history in Alzheimer's disease and frontotemporal dementia","volume":"13","author":"Lagan\u00e0","year":"2022","journal-title":"Front Neurol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1263771","DOI":"10.3389\/fnins.2023.1263771","article-title":"Understanding neuropsychiatric symptoms in Alzheimer's disease: challenges and advances in diagnosis and treatment","volume":"17","author":"Pless","year":"2023","journal-title":"Front Neurosci"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s13205-022-03123-4","article-title":"Hippocampus and its involvement in Alzheimer's disease: a review","volume":"12","author":"Rao","year":"2022","journal-title":"3 Biotech"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s13287-024-03737-w","article-title":"Promoting Alzheimer's disease research and therapy with stem cell technology","volume":"15","author":"Cao","year":"2024","journal-title":"Stem Cell Res Ther"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"2002944","DOI":"10.1002\/advs.202002944","article-title":"Mesenchymal stem cells for neurological disorders","volume":"8","author":"Andrzejewska","year":"2021","journal-title":"Adv Sci"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.4103\/1673-5374.361546","article-title":"Mesenchymal stem cell- and extracellular vesicle-based therapies for Alzheimer's disease: progress, advantages, and challenges","volume":"18","author":"Gon\u00e7alves","year":"2023","journal-title":"Neural Regen Res"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1903809","DOI":"10.1002\/advs.201903809","article-title":"HGF mediates clinical-grade human umbilical cord-derived mesenchymal stem cells improved functional recovery in a senescence-accelerated mouse model of Alzheimer's disease","volume":"7","author":"Jia","year":"2020","journal-title":"Adv Sci"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"104","DOI":"10.2174\/1567205013666161004151416","article-title":"Human umbilical cord stem cell xenografts improve cognitive decline and reduce the amyloid burden in a mouse model of Alzheimer's disease","volume":"14","author":"Boutajangout","year":"2017","journal-title":"Curr Alzheimer Res"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.bbr.2016.12.021","article-title":"Human umbilical cord mesenchymal stem cells transplantation improves cognitive function in Alzheimer's disease mice by decreasing oxidative stress and promoting hippocampal neurogenesis","volume":"320","author":"Cui","year":"2017","journal-title":"Behav Brain Res"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.jconrel.2020.02.035","article-title":"Magnetic targeted delivery of the SPIONs-labeled mesenchymal stem cells derived from human Wharton's jelly in Alzheimer's rat models","volume":"321","author":"Hour","year":"2020","journal-title":"J Control Release"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1538\/expanim.22-0164","article-title":"The past and present of therapeutic strategy for Alzheimer's diseases: potential for stem cell therapy","volume":"72","author":"Murayama","year":"2023","journal-title":"Exp Anim"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"e70273","DOI":"10.1002\/alz.70273","article-title":"Experimental modeling of Alzheimer's disease: translational lessons from cross-taxon analyses","volume":"21","author":"Yenkoyan","year":"2025","journal-title":"Alzheimers Dement"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1646551","DOI":"10.3389\/fnagi.2025.1646551","article-title":"Advancement in modeling of Alzheimer's disease: a comprehensive review of preclinical screening platforms","volume":"17","author":"Adak","year":"2025","journal-title":"Front Aging Neurosci"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1538\/expanim.21-0120","article-title":"Morris water maze: a versatile and pertinent tool for assessing spatial learning and memory","volume":"71","author":"Othman","year":"2022","journal-title":"Exp Anim"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1177\/13872877251366669","article-title":"Clinical observations on treating Alzheimer's disease with umbilical cord blood mononuclear cells","volume":"107","author":"Chen","year":"2025","journal-title":"J Alzheimer's Dis"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.7150\/thno.81860","article-title":"Engineered mesenchymal stem cell-derived extracellular vesicles: a state-of-the-art multifunctional weapon against Alzheimer's disease","volume":"13","author":"Yin","year":"2023","journal-title":"Theranostics"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"102507","DOI":"10.1016\/j.nano.2021.102507","article-title":"Fe(3)O(4)@polydopamine nanoparticle-loaded human umbilical cord mesenchymal stem cells improve the cognitive function in Alzheimer's disease mice by promoting hippocampal neurogenesis","volume":"40","author":"Wang","year":"2022","journal-title":"Nanomedicine"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.bbr.2017.10.032","article-title":"Resveratrol promotes hUC-MSCs engraftment and neural repair in a mouse model of Alzheimer's disease","volume":"339","author":"Wang","year":"2018","journal-title":"Behav Brain Res"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13287-017-0756-2","article-title":"Autophagy is required for human umbilical cord mesenchymal stem cells to improve spatial working memory in APP\/PS1 transgenic mouse model","volume":"9","author":"Li","year":"2018","journal-title":"Stem Cell Res Ther"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/s13287-022-02876-2","article-title":"Potential mechanisms and therapeutic targets of mesenchymal stem cell transplantation for ischemic stroke","volume":"13","author":"Zhou","year":"2022","journal-title":"Stem Cell Res Ther"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"5675","DOI":"10.7150\/thno.46436","article-title":"Application of mesenchymal stem cell therapy for aging frailty: from mechanisms to therapeutics","volume":"11","author":"Zhu","year":"2021","journal-title":"Theranostics"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12974-019-1400-0","article-title":"The spleen may be an important target of stem cell therapy for stroke","volume":"16","author":"Wang","year":"2019","journal-title":"J Neuroinflammation"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1002\/glia.22500","article-title":"How stem cells speak with host immune cells in inflammatory brain diseases","volume":"61","author":"Pluchino","year":"2013","journal-title":"Glia"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41583-025-00985-4","article-title":"Stem cell-mediated recovery in stroke: partnering with the immune system","volume":"27","author":"McMillan","year":"2026","journal-title":"Nat Rev Neurosci"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1538\/expanim.21-0008","article-title":"Dementia model mice exhibited improvements of neuropsychiatric symptoms as well as cognitive dysfunction with neural cell transplantation","volume":"70","author":"Murayama","year":"2021","journal-title":"Exp Anim"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1196\/annals.1386.008","article-title":"Age-related inflammatory diseases: role of genetics and gender in the pathophysiology of Alzheimer's disease","volume":"1089","author":"Candore","year":"2006","journal-title":"Ann N Y Acad Sci"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"6354","DOI":"10.3390\/ijms24076354","article-title":"Sex and gender differences in neurodegenerative diseases: challenges for therapeutic opportunities","volume":"24","author":"Bianco","year":"2023","journal-title":"Int J Mol Sci"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2026.1783757\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T05:21:08Z","timestamp":1772428868000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2026.1783757\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,2]]},"references-count":33,"alternative-id":["10.3389\/fneur.2026.1783757"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2026.1783757","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,2]]},"article-number":"1783757"}}